GlobeNewsWire · EPP · October 18, 2026

Disc Medicine to Host Corporate Webcast to Discuss Topline Results from the APOLLO Phase 3 Trial of Bitopertin in Erythropoietic Protoporphyria (EPP)

Get the app for more

Explore stock news, insights and company research.